Literature DB >> 6704952

Effect of a subcutaneously growing Walker 256 carcinosarcoma on host tissue mitochondrial function and magnesium content.

J Cummings, N Willmott, K C Calman.   

Abstract

Mitochondria were prepared from the liver, kidneys, and skeletal muscle of rats at 1, 6, 12, 18, and 26 days after inoculation with Walker 256 cells or sterile 0.9% NaCl solution and assessed for structural and functional integrity. Using polarography to measure respiration, it was found that all tissue mitochondria from both controls and tumor-bearing animals prepared 1 day after inoculations were damaged and had impaired respiratory function. This effect was believed to be caused by the presence of anesthetic molecules in the mitochondrial membranes rather than by tumor. On Day 6, all tissue mitochondria were respiring properly; no evidence of membrane disruption was apparent. From Day 12 onwards, mitochondria from the tumor-bearing animals would not consume oxygen unless magnesium ions were added to incubation media. Kidney required by far the greatest amount of magnesium, in one case, 10 mM MgCl2. The requirement of the liver never exceeded 3 mM MgCl2, and with the muscle no dependency developed. The quantity of magnesium ions necessary to restore normal kidney mitochondrial function increased with tumor size (r = 0.83). From Day 12 onwards, mitochondria prepared from the control animals respired normally, and all mitochondria from the controls and the tumor-bearing rats were structurally intact. When the magnesium content of the abnormal mitochondria prepared from the animals inoculated with tumor cells was measured by atomic absorption spectrophotometry, the mitochondria were found to be deficient by 18% for kidney (p less than 0.01) and 20% for liver (p less than 0.01) compared to controls (Student's t test).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6704952

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  1 in total

1.  Targeted overexpression of mitochondrial catalase protects against cancer chemotherapy-induced skeletal muscle dysfunction.

Authors:  Laura A A Gilliam; Daniel S Lark; Lauren R Reese; Maria J Torres; Terence E Ryan; Chien-Te Lin; Brook L Cathey; P Darrell Neufer
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-21       Impact factor: 4.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.